Eric Thomas Schmidt

Insider Reports History

Identity Who this page is about. 1 identity field
Location
South San Francisco, CA
SEC source record Original filing metadata and source links. 1 source field
Owner filing signature
/s/ Jack Anders, as Attorney-in-fact for Eric Schmidt
Source evidence Original filing metadata and source links. 1 source field

Reported holdings for Eric Thomas Schmidt

Form 4 holding Chief Financial Officer

Allogene Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,152,595
Estimated value
$3,658,798
Report date
22 Mar 2023
Price
$3.17
Ownership
Indirect
Form 4 holding Chief Financial Officer

Allogene Therapeutics, Inc.

Security class
Common Stock
Shares / value
862,439
Estimated value
$2,737,726
Report date
22 Mar 2023
Price
$3.17
Ownership
Direct
Form 4 holding Chief Financial Officer

Allogene Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
432,738
Estimated value
Report date
22 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

RELMADA THERAPEUTICS, INC.

Security class
Stock Option (right to buy)
Shares / value
150,000
Estimated value
Report date
25 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Revolution Medicines, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
18,400
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Eric Thomas Schmidt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .